Effects of enoximone on right-ventricular function in patients with impaired myocardial performance

Thoracic and Cardiovascular Surgeon

Volumn 44, Issue 4, 1996, Pages 173-177

  Retry, A ^a   Dutschke P ^a   Regensburger, D ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Cardiac surgery; Enoximone; Haemodynamics; Phosphodiesterase III inhibitors; Right ventricular function

Indexed keywords

ANESTHETIC AGENT; ENOXIMONE; FENTANYL; FLUNITRAZEPAM; PANCURONIUM; PHOSPHODIESTERASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; ENZYME INHIBITION; GENERAL ANESTHESIA; HEART MUSCLE REVASCULARIZATION; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029795446     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1012011     Document Type: Article

References (24)

1. Assmann, R., C. F. Heidelmeyer, H. J. Trampisch, K. Mottaghy, A. Versprille, W. Sandmann, and K.J. Falke: Right-ventricular function assessed by thermodilution technique during apnea and mechanical ventilation. Crit. Care Med. 19 (1991) 810-817
2. Birnbaum, D. E., J. G. Preuner, R. Gieseke, W. Kasper-König, et al.: Comparison of intravenous enoximone and dopamine on hemodynamics after extracorporeal circulation in patients with aortocoronary venous bypass. Z. Kardiol. 80 (1991 ) Suppl. 4: 47-52
3. Boldt, J., and G. Hempelmann: Hemodynamic effects of the phosphodiesterase inhibitor enoximone in cardiac surgery. Z. Kardiol. 80 (1991) Suppl. 4:41-46
4. Boldt, J., D. Kling, E. Schumann, F. Dapper, and G. Hempelmann: Hemodynamic effects of the new phosphodiesterase inhibitor enoximone in patients undergoing heart surgery. Anaesthesist 38 (1989) 238-244
5. Dage, R. C., and R. A. Okerholm: Pharmacology and pharmacokinetics of enoximone. Cardiology 77 (1990) Suppl. 3: 2-13
6. Dupuis, J.-Y., R. Bondy, C. Cattran, H. J. Nathan, and J. E. Wynands: Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome. J. Cardiothorac. vasc. Anesth. 6 (1992) 542-553
7. rd ed. Philadelphia, Saunders, 1993 pp. 1095-1121
8. Hoeft, A., H. Sonntag, H. Stephan, and D. Kettler: Validation of myocardial oxygen demand indices in patients awake and during anaesthesia. Anesthesiology 75 (1991) 49-56
9. Holubarsch, Ch., G. Hasenfuß, L. Thierfelder, H. W. Heiss, and H. Just: Vasodilation and inotropism of the phosphodiesterase inhibitor enoximone. Z. Kardiol. 80 (1991) Suppl. 4: 35-40
10. Keogh, B., R. Priddy, C. Morgan, and C. Gillbe: Comparative study of the effects of enoximone and dobutamine in patients with impaired left-ventricular function undergoing cardiac surgery. Cardiology 77 (1990) Suppl. 3: 58-61
11. Levy, J. H., and J. M. Bailey: Perioperative experience with amrinone. Eur. J. Anaesth. 5 (1992) Suppl. 1:15-19
12. Levy, J. H.: Support of the perioperative failing heart with preexisting ventricular dysfunction: currently available options. J. Cardiothorac. vasc. Anesth. 7 (1993) Suppl. 2: 46-51
13. Masuoka, H., M. Ito, T. Nakano, M. Naka, and T. Tanaka: Effects of amrinone and enoximone on the subclasses of cyclic AMP phosphodiesterase from human heart and kidney. J. Cardiovasc. Pharmacol. 15 (1990) 302-307
14. Mitrovic, V., J. Neuzner, H. Opper, J. Thormann, and M. Schlepper: Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine. Z. Kardiol. 83 (1994) Suppl. 2: 37-48
15. O'Connell, J. B., E. M. Gilbert, D. G. Renlund, and M. R. Bristow: Enoximone as a bridge to heart transplantation: the Utah experience. J. Heart Lung Transplant. 10 (1991) 477-481
16. Petry, A., and P. Dütschke: Effects of amrinone on left- and right-ventricular function in patients with impaired myocardial performance during general anaesthesia. Br. J. Anaesth. 72 (1994) 567-570
17. Schlepper, M., V. Mitrovic, and J. Thormann: Inhibitor drugs in ischemic coronary artery disease. Z. Kardiol. 80 (1991) Suppl. 4: 75-83
18. Schlepper, M.: The anti-ischemic effect of phosphodiesterase III inhibitors. Z. Kardiol. 83 (1994) Suppl. 2: 27-36
19. Schwinn, D. A, B. J. Leone, D. R. Spahn, et al.: Desensitization of myocardial beta-adrenergic receptors during cardiopulmonary bypass, evidence for early uncoupling and late downregulation. Circulation 84 (1991) 2559-2567
20. Slogoff, S., and A. S. Keats: Does chronic treatment with calcium entry blocking drugs reduce perioperative myocardial ischemia? Anesthesiology 68 (1988) 676-680
21. Spinale, F. G., A, C. Smith, B. A. Carabello, and F. A. Crawford: Right-ventricular function computed by thermodilution and ventriculography. J. Thorac. Cardiovasc. Surg. 99 (1990) 141-152
22. Stephan, H., S. Kazmaier, A. Hoeft, and H. Sonntag: Effects of enoximone an R 80122, a new selective phosphodiesterase III inhibitor, on hemodynamics and myocardial energetics in patients with ischemic heart disease. Anesth. and Analg. 79 (1994) 1059-1065
23. Stetz, C. W., R. G. Miller, C. E. Kelly, and T. A. Raffin: Reliability of the thermodilution method in the determination of cardiac output in clinical practice. Am. Rev. Respir. Dis. 126 (1982) 1001-1004
24. Urban, P., D. Scheidegger, J. Cabathuler, and W. Rutishauser: Thermodilution determination of right-ventricular volume and ejection fraction: A comparison with biplane angiography. Cirt. Care Med. 15 (1987) 652-655